Croda International Plc (LON:CRDA – Get Free Report) insider Steve Foots purchased 5 shares of the stock in a transaction dated Tuesday, February 10th. The shares were acquired at an average price of GBX 3,100 per share, for a total transaction of £155.
Steve Foots also recently made the following trade(s):
- On Monday, January 12th, Steve Foots acquired 5 shares of Croda International stock. The stock was bought at an average price of GBX 2,714 per share, for a total transaction of £135.70.
- On Wednesday, December 10th, Steve Foots bought 6 shares of Croda International stock. The shares were bought at an average cost of GBX 2,687 per share, with a total value of £161.22.
Croda International Price Performance
CRDA opened at GBX 3,188 on Thursday. The company has a current ratio of 2.72, a quick ratio of 2.25 and a debt-to-equity ratio of 30.90. Croda International Plc has a 1 year low of GBX 2,426.77 and a 1 year high of GBX 3,372.60. The stock has a fifty day moving average price of GBX 2,762.10 and a 200 day moving average price of GBX 2,712.59. The stock has a market cap of £4.45 billion, a price-to-earnings ratio of 20.70, a PEG ratio of 1.40 and a beta of 0.74.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on CRDA
About Croda International
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
Recommended Stories
- Five stocks we like better than Croda International
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Trump’s Hand-Written Letter Will Shock his Haters
- Trump’s national nightmare is here
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
